Street View: Multiple brokerages lift Marriott's PT, citing upcoming credit card deal optimism
Multiple brokerages lift Marriott International MAR.O PT after co raised its 2025 profit forecast, banking on resilient demand for luxury accommodation and upcoming credit card deal optimism
Shares of Marriott rise nearly 3.5% to about $281.8 in early trading after they rose about 3.2% yesterday
10 of 27 brokerages rate the stock "buy" or higher, 16 "hold" and one "sell"; their median PT is $288 - data compiled by LSEG
As of last close, shares up about 2.7% YTD
CREDIT CARD DEAL OPTIMISM AND LUXURY ACCOMODATION DEMAND
Mizuho (lifts PT to $297 from $274) says MAR's upcoming credit card deal renewal with Amex/Chase, which could be meaningful, contributing ~$719 mln in 2025 and the brokerage estimates ~$780 mln in 2026
J.P.Morgan (lifts PT to $294 from $281) says renegotiated credit card fees serve as a positive catalyst and could drive upside to FY26/27 estimates
BMO (lifts PT to $285 from $280) says MAR remains relatively better positioned versus peers with higher-end and international markets strength
Related Articles
Tesla’s 2025 Shareholder Meeting Showdown: Musk’s Leadership and Tesla’s Crossroads
TradingKey - Tesla (TSLA), the electric vehicle leader, will hold its 2025 Annual Shareholder Meeting on November 6. Dubbed by CEO Elon Musk as a moment that will “decide Tesla’s future and shape the world’s,” the event centers on one pivotal question: Will shareholders approve Musk’s proposed $1 T
What Drove the 'Black Tuesday' Sell-Off? Three Key Factors Behind the U.S. Stock Plunge
TradingKey - On November 4, 2025, U.S. markets suffered a sudden and sharp selloff — dubbed “Black Tuesday” — with the Nasdaq posting its largest single-day drop in a month. The rout unfolded amid growing economic and political instability, as a record-long government shutdown worsened systemic
IonQ Stock Price Skyrockets 300% in a Year, But Recently Drops 30%—Is IonQ Still a Buy?
Is IonQ worth buying? With a recent decline of nearly 30% over the past month, is now the time to buy? How much further could IonQ's stock rise?
Novo Nordisk Q3 Earnings Preview: New CEO, Board Overhaul — Can the U.S. Weight-Loss Market Turn Around?
TradingKey - Novo Nordisk (NVO), one of Europe’s pharmaceutical giants and a leader in the weight-loss drug race, will report its Q3 2025 earnings before market open on November 5. Wall Street expects a modest rebound from Q2’s worst growth in four years, but significant pressure on profits remains.
Palantir Q3 2025 Earnings: Blowout Performance Can’t Hide an AI Bubble， Four Growing Risks Behind a Nearly 1,000x Valuation
TradingKey – After the close of trading on November 4, “AI application King” Palantir Technologies (PLTR) reported its third-quarter earnings for fiscal year 2025. Despite a blowout quarter, surging top-line growth, and a flood of commercial orders, the stock plunged in after-hours trading.
